FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Luc Galzi

Research Profile

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequences

Concepts & Ideas

Physiology

Anatomy

Living Beings

Torpedo

Procedures

Fluorescence Resonance Energy Transfer

Co-author Network

Publications

TOP 3
Muriel Hachet-Haas; Karl Balabanian; François Rohmer; Françoise Pons; Christel Franchet; Sandra Lecat; Ken Y C Chow; Rania Dagher; Patrick Gizzi; Bruno Didier; Bernard Lagane; Esther Kellenberger; Dominique Bonnet; Françoise Baleux; jacques haiech; Marc Parmentier; Nelly Frossard; Fernando Arenzana-Seisdedos; Marcel Hibert; Jean-Luc Galzi
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
Moussa Ouedraogo; Sandra Lecat; Moulay Driss Rochdi; Muriel Hachet-Haas; Hans Matthes; Hervé Gicquiaux; Sophie Verrier; Mireille Gaire; Nicole Glasser; Yves Mély; Kenneth Takeda; Michel Bouvier; Jean-Luc Galzi; Bernard Bucher
Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
Emeline Maillet; Nadia Pellegrini; Celine Valant; Bernard Bucher; Marcel Hibert; Jean-Jacques Bourguignon; Jean-Luc Galzi
A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Luc Galzi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Muriel Hachet-Haas; Karl Balabanian; François Rohmer; Françoise Pons; Christel Franchet; Sandra Lecat; Ken Y C Chow; Rania Dagher; Patrick Gizzi; Bruno Didier; Bernard Lagane; Esther Kellenberger; Dominique Bonnet; Françoise Baleux; jacques haiech; Marc Parmentier; Nelly Frossard; Fernando Arenzana-Seisdedos; Marcel Hibert; Jean-Luc Galzi
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
The Journal of biological chemistry 2008;283(34):23189-99.
2008: Moussa Ouedraogo; Sandra Lecat; Moulay Driss Rochdi; Muriel Hachet-Haas; Hans Matthes; Hervé Gicquiaux; Sophie Verrier; Mireille Gaire; Nicole Glasser; Yves Mély; Kenneth Takeda; Michel Bouvier; Jean-Luc Galzi; Bernard Bucher
Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
Traffic (Copenhagen, Denmark) 2008;9(3):305-24.
2007: Emeline Maillet; Nadia Pellegrini; Celine Valant; Bernard Bucher; Marcel Hibert; Jean-Jacques Bourguignon; Jean-Luc Galzi
A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(9):2124-34.
2007: Sannah Zoffmann; Sonia Bertrand; Quoc-Tuan Do; Daniel Bertrand; Didier Rognan; Marcel Hibert; Jean-Luc Galzi
Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor.
Journal of neurochemistry 2007;101(2):506-16.
2007: Esther Kellenberger; Jean-Yves Springael; Marc Parmentier; Muriel Hachet-Haas; Jean-Luc Galzi; Didier Rognan
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
Journal of medicinal chemistry 2007;50(6):1294-303.
2006: Muriel Hachet-Haas; Noël Converset; Olivier Marchal; Hans Matthes; Sophie Gioria; Jean-Luc Galzi; Sandra Lecat
FRET and colocalization analyzer--a method to validate measurements of sensitized emission FRET acquired by confocal microscopy and available as an ImageJ Plug-in.
Microscopy research and technique 2006;69(12):941-56.
2006: Dominique Bonnet; Brigitte Ilien; Jean-Luc Galzi; Stéphanie Riché; Cyril Antheaune; Marcel Hibert
A rapid and versatile method to label receptor ligands using "click" chemistry: Validation with the muscarinic M1 antagonist pirenzepine.
Bioconjugate chemistry 2006;17(6):1618-23.
2005: Chouaib Tahtaoui; Fabrice Guillier; Philippe Klotz; Jean-Luc Galzi; Marcel Hibert; Brigitte Ilien
On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies.
Journal of medicinal chemistry 2005;48(24):7847-59.
2005: David Cluet; Christophe Bertsch; Christian Beyer; Liliane Gloeckler; Mathieu Erhardt; Jean-Pierre Gut; Jean-Luc Galzi; Anne-Marie Aubertin
Detection of human immunodeficiency virus type 1 Nef and CD4 physical interaction in living human cells by using bioluminescence resonance energy transfer.
Journal of virology 2005;79(13):8629-36.
2005: Anthony Baurand; Anita Eckly; Béatrice Hechler; Gilles kauffenstein; Jean-Luc Galzi; Jean-Pierre Cazenave; Catherine Léon; Christian Gachet
Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties?
Molecular pharmacology 2005;67(3):721-33.
2004: Laurence Cézanne; Sandra Lecat; Bernard Lagane; Claire Millot; Jean-Yves Vollmer; Hans Matthes; Jean-Luc Galzi; André Lopez
Dynamic confinement of NK2 receptors in the plasma membrane. Improved FRAP analysis and biological relevance.
The Journal of biological chemistry 2004;279(43):45057-67.
2004: Chouaib Tahtaoui; Isabelle Parrot; Philippe Klotz; Fabrice Guillier; Jean-Luc Galzi; Marcel Hibert; Brigitte Ilien
Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor.
Journal of medicinal chemistry 2004;47(17):4300-15.
2003: Brigitte Ilien; Christelle Franchet; Philippe Bernard; Séverine Morisset; Claire Odile Weill; Jean-Jacques Bourguignon; Marcel Hibert; Jean-Luc Galzi
Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties.
Journal of neurochemistry 2003;85(3):768-78.
2002: Sandra Lecat; Bernard Bucher; Yves Mely; Jean-Luc Galzi
Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses.
The Journal of biological chemistry 2002;277(44):42034-48.
2002: Sannah Zoffmann; André Chollet; Jean-Luc Galzi
Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor.
Molecular pharmacology 2002;62(3):729-36.
2002: Hervé Gicquiaux; Sandra Lecat; Mireille Gaire; Alain Dieterlen; Yves Mély; Kenneth Takeda; Bernard Bucher; Jean-Luc Galzi
Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor.
The Journal of biological chemistry 2002;277(8):6645-55.
2001: T Palanche; Brigitte Ilien; Sannah Zoffmann; M P Reck; Bernard Bucher; S J Edelstein; Jean-Luc Galzi
The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states.
The Journal of biological chemistry 2001;276(37):34853-61.
2001: Agustín Valenzuela-Fernández; T Palanche; Ali Amara; A Magerus; Ralf Altmeyer; Thierry Delaunay; Jean-Louis Virelizier; Françoise Baleux; Jean-Luc Galzi; Fernando Arenzana-Seisdedos
Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans.
The Journal of biological chemistry 2001;276(28):26550-8.
2001: Ronald J. Lukas; Linda Lucero; B Buisson; Jean-Luc Galzi; E Puchacz; John D Fryer; Jean-Pierre Changeux; Daniel Bertrand
Neurotoxicity of channel mutations in heterologously expressed alpha7-nicotinic acetylcholine receptors.
The European journal of neuroscience 2001;13(10):1849-60.
2001: Sannah Zoffmann; G Turcatti; Jean-Luc Galzi; M Dahl; André Chollet
Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
Journal of medicinal chemistry 2001;44(2):215-22.
1999: J Y Vollmer; P Alix; André Chollet; K Takeda; Jean-Luc Galzi
Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors.
The Journal of biological chemistry 1999;274(53):37915-22.
1999: Claire Odile Weill; Jean-Luc Galzi; S Chasserot-Golaz; Maurice Goeldner; Brigitte Ilien
Functional characterization and potential applications for enhanced green fluorescent protein- and epitope-fused human M1 muscarinic receptors.
Journal of neurochemistry 1999;73(2):791-801.
1999: Pierre-Jean Corringer; Sonia Bertrand; Jean-Luc Galzi; Anne Devillers-Thiéry; Jean-Pierre Changeux; Daniel Bertrand
Mutational analysis of the charge selectivity filter of the alpha7 nicotinic acetylcholine receptor.
Neuron 1999;22(4):831-43.
1999: Pierre-Jean Corringer; Sonia Bertrand; Jean-Luc Galzi; Anne Devillers-Thiéry; Jean-Pierre Changeux; Daniel Bertrand
Molecular basis of the charge selectivity of nicotinic acetylcholine receptor and related ligand-gated ion channels.
Novartis Foundation symposium 1999;225():215-24; discussion 224-30.
1999: Claire Odile Weill; Brigitte Ilien; Maurice Goeldner; Jean-Luc Galzi
Fluorescent muscarinic EGFP-hM1 chimeric receptors: design, ligand binding and functional properties.
Journal of receptor and signal transduction research 1999;19(1-4):423-36.
1998: R M Krause; B Buisson; Sonia Bertrand; Pierre-Jean Corringer; Jean-Luc Galzi; Jean-Pierre Changeux; Daniel Bertrand
Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.
Molecular pharmacology 1998;53(2):283-94.
1996: Jean-Luc Galzi; Sonia Bertrand; Pierre-Jean Corringer; Jean-Pierre Changeux; Daniel Bertrand
Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor.
The EMBO journal 1996;15(21):5824-32.
1996: Jean-Luc Galzi; Stuart J Edelstein; Jean-Pierre Changeux
The multiple phenotypes of allosteric receptor mutants.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(5):1853-8.
1995: Jean-Luc Galzi; Jean-Pierre Changeux
Neuronal nicotinic receptors: molecular organization and regulations.
Neuropharmacology 1995;34(6):563-82.
1995: Pierre-Jean Corringer; Jean-Luc Galzi; J L Eiselé; Sonia Bertrand; Jean-Pierre Changeux; Daniel Bertrand
Identification of a new component of the agonist binding site of the nicotinic alpha 7 homooligomeric receptor.
The Journal of biological chemistry 1995;270(20):11749-52.
1993: J L Eiselé; Sonia Bertrand; Jean-Luc Galzi; Anne Devillers-Thiéry; Jean-Pierre Changeux; Daniel Bertrand
Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities.
Nature 1993;366(6454):479-83.
1993: Anne Devillers-Thiéry; Jean-Luc Galzi; J L Eiselé; Sonia Bertrand; Daniel Bertrand; Jean-Pierre Changeux
Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels.
The Journal of membrane biology 1993;136(2):97-112.
1993: Daniel Bertrand; Jean-Luc Galzi; Anne Devillers-Thiéry; Sonia Bertrand; Jean-Pierre Changeux
Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(15):6971-5.
1993: Daniel Bertrand; Jean-Luc Galzi; Anne Devillers-Thiéry; Sonia Bertrand; Jean-Pierre Changeux
Stratification of the channel domain in neurotransmitter receptors.
Current opinion in cell biology 1993;5(4):688-93.
1992: Jean-Pierre Changeux; Jean-Luc Galzi; Anne Devillers-Thiéry; Daniel Bertrand
The functional architecture of the acetylcholine nicotinic receptor explored by affinity labelling and site-directed mutagenesis.
Quarterly reviews of biophysics 1992;25(4):395-432.
1992: Anne Devillers-Thiéry; Jean-Luc Galzi; Sonia Bertrand; Jean-Pierre Changeux; Daniel Bertrand
Stratified organization of the nicotinic acetylcholine receptor channel.
Neuroreport 1992;3(11):1001-4.
1992: Jean-Luc Galzi; Anne Devillers-Thiéry; N Hussy; Sonia Bertrand; Jean-Pierre Changeux; Daniel Bertrand
Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic.
Nature 1992;359(6395):500-5.
1992: Jean-Pierre Changeux; Anne Devillers-Thiéry; Jean-Luc Galzi; Daniel Bertrand
New mutants to explore nicotinic receptor functions.
Trends in pharmacological sciences 1992;13(8):299-301.
1992: Daniel Bertrand; Anne Devillers-Thiéry; F Revah; Jean-Luc Galzi; N Hussy; C Mulle; Sonia Bertrand; Marc Ballivet; Jean-Pierre Changeux
Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(4):1261-5.
1992: Jean-Pierre Changeux; Anne Devillers-Thiéry; Jean-Luc Galzi; F Revah
The acetylcholine receptor: a model of an allosteric membrane protein mediating intercellular communication.
Ciba Foundation symposium 1992;164():66-89; discussion 87-97.
1991: Jean-Luc Galzi; Daniel Bertrand; Anne Devillers-Thiéry; F Revah; Sonia Bertrand; Jean-Pierre Changeux
Functional significance of aromatic amino acids from three peptide loops of the alpha 7 neuronal nicotinic receptor site investigated by site-directed mutagenesis.
FEBS letters 1991;294(3):198-202.
1991: F Revah; Daniel Bertrand; Jean-Luc Galzi; Anne Devillers-Thiéry; C Mulle; N Hussy; Sonia Bertrand; Marc Ballivet; Jean-Pierre Changeux
Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor.
Nature 1991;353(6347):846-9.
1991: Jean-Luc Galzi; F Revah; F Bouet; A Ménez; Maurice Goeldner; C Hirth; Jean-Pierre Changeux
Allosteric transitions of the acetylcholine receptor probed at the amino acid level with a photolabile cholinergic ligand.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(11):5051-5.
1991: Jean-Luc Galzi; F Revah; A Bessis; Jean-Pierre Changeux
Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain.
Annual review of pharmacology and toxicology 1991;31():37-72.
1990: Jean-Luc Galzi; A Mejean; Brigitte Ilien; C Mollereau; J C Meunier; Maurice Goeldner; C Hirth
Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor.
Journal of medicinal chemistry 1990;33(9):2456-64.
1990: Jean-Luc Galzi; F Revah; D Black; Maurice Goeldner; C Hirth; Jean-Pierre Changeux
Identification of a novel amino acid alpha-tyrosine 93 within the cholinergic ligands-binding sites of the acetylcholine receptor by photoaffinity labeling. Additional evidence for a three-loop model of the cholinergic ligands-binding sites.
The Journal of biological chemistry 1990;265(18):10430-7.
1990: Jean-Luc Galzi; A Mejean; Maurice Goeldner; C Hirth; Brigitte Ilien
Photoaffinity labelling of the mu-opioid receptor is dependent on the nature of the photosensitive group of carfentanil derivatives.
European journal of pharmacology 1990;188(6):321-8.
1990: F Revah; Jean-Luc Galzi; J Giraudat; P Y Haumont; Florence Lederer; Jean-Pierre Changeux
The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(12):4675-9.
1990: Jean-Pierre Changeux; P Benoît; A Bessis; Jean Cartaud; Anne Devillers-Thiéry; B Fontaine; Jean-Luc Galzi; A Klarsfeld; R Laufer; C Mulle
Regulation of acetylcholine receptor gene expression by neural factors and electrical activity during motor endplate formation.
Biochemical Society symposium 1990;56():9-12.
1990: Jean-Pierre Changeux; P Benoit; A Bessis; Jean Cartaud; A Devillers-Thiery; B Fontaine; Jean-Luc Galzi; A Klarsfeld; R Laufer; C Mulle
The acetylcholine receptor: functional architecture and regulation.
Advances in second messenger and phosphoprotein research 1990;24():15-9.
1988: Brigitte Ilien; Jean-Luc Galzi; A Mejean; Maurice Goeldner; C Hirth
A mu-opioid receptor-filter assay. Rapid estimation of binding affinity of ligands and reversibility of long-lasting ligand-receptor complexes.
Biochemical pharmacology 1988;37(20):3843-51.